Daphne Quimi - 12 Sep 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Reporting relationship: Director
Issuer ticker: IPSC
Reported as of: 12 Sep 2024
Net transaction value: +$7,657
SEC form: 4
Accepted by SEC: 16 Sep 2024, 16:18:18 UTC
Prior SEC filing: 21 Jun 2024
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Douglas Carr, Attorney-in-Fact

Key filing fact

Daphne Quimi filed Form 4 for Century Therapeutics, Inc. (IPSC) on 16 Sep 2024.

Key facts

This page summarizes Daphne Quimi's Form 4 filing for Century Therapeutics, Inc. (IPSC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Sep 2024, 16:18.

Change

Previous filing in this sequence was filed on 21 Jun 2024.
Current net transaction value: +$7,657.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IPSC transaction

Common Stock

Purchase

Transaction value: $7,657
Shares: +5,000
Change %
Price: $1.53
Shares after: 5,000
Date: 12 Sep 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.525 to $1.54. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.